Name of the institute: INSERM U1065, Mediterranean Center for Molecular Medicine (C3M).
Name of the team: Metabolism, Cancer and Immune response
Name of the leader: JE RICCI, PhD
Location: Nice, France.
Abstract of the project: We recently established that reducing the dietary intake of mice that develop B lymphomas by 25% a week was sufficient to reduce Mcl-1 expression and sensitize those mice to the targeted chemotherapy (Meynet et al Blood 2013, Meynet et al Trends Mol Med 2015). Using cutting edge technologies the PhD student will comprehensively detect the global cellular changes induced by specific diets in RNA, protein, cytokine and immune response. The project will be conducted in cell lines, murine and human primary cells as well as in vivo.
As part of our MSCA-ESR training on complementary skills we got to leave the wet lab to explore what happens on the other side of the bench and to learn what it means to be a scientific editor. This is our story.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766214.
Bellvitge Biomedical
Research Institute (IDIBELL)
Hospital Duran i Reynals, 3a planta
Gran Via de l’Hospitalet, 199
08908 L’Hospitalet del Llobregat
Barcelona, Spain
